| abstract |
Novel forms of [R, (R*,R*)]- 2 -( 4 -Fluorophenyl)-β,δdihydroxy- 5 -methylethyl)- 3 -phenyl- 4 -[(phenylamino)carbonyl]- 1 -H-pyrrole- 1 -heptanoic acid hemi calcium salt designated Form XX, Form XXI, Form XXII, Form XXIII, Form XXIV, Forms XXV, Form XXVII, Form XXVIII, Form XXXIX, and Forms XXX, characterized by their X-ray powder diffractor, solid state NMR, and/or Raman spectroscopy are describes as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPH) and Alzheimer) disease. |